Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 178

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus

Open access
Schünemann, Holger J, Hill, Suzanne R, Kakad, Meetali, Bellamy, Richard, Uyeki, Timothy M, Hayden, Frederick G, Yazdanpanah, Yazdan, Beigel, John, Chotpitayasunondh, Tawee, Del Mar, Chris, Farrar, Jeremy, Hien, Tran Tinh, Özbay, Bülent, Sugaya, Norio, Fukuda, Keiji, Shindo, Nikki, Stockman, Lauren, Vist, Gunn E, Croisier, Alice, Nagjdaliyev, Azim, Roth, Cathy, Thomson, Gail, Zucker, Howard, Oxman, Andrew D · 2007 · The Lancet Infectious Diseases

Abstract

Recent spread of avian influenza A (H5N1) virus to poultry and wild birds has increased the threat of human infections with H5N1 virus worldwide. Despite international agreement to stockpile antivirals, evidence-based guidelines for their use do not exist. WHO assembled an international multidisciplinary panel to develop rapid advice for the pharmacological management of human H5N1 virus infection in the current pandemic alert period. A transparent methodological guideline process on the basis of the Grading Recommendations, Assessment, Development and Evaluation (GRADE) approach was used to develop evidence-based guidelines. Our development of specific recommendations for treatment and chemoprophylaxis of sporadic H5N1 infection resulted from the benefits, harms, burden, and cost of interventions in several patient and exposure groups. Overall, the quality of the underlying evidence for all recommendations was rated as very low because it was based on small case series of H5N1 patients, on extrapolation from preclinical studies, and high quality studies of seasonal influenza. A strong recommendation to treat H5N1 patients with oseltamivir was made in part because of the severity of the disease. Similarly, strong recommendations were made to use neuraminidase inhibitors as chemoprophylaxis in high-risk exposure populations. Emergence of other novel influenza A viral subtypes with pandemic potential, or changes in the pathogenicity of H5N1 virus strains, will require an update of these guidelines and WHO will be monitoring this closely.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(06)70684-3

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 178

Metadata

Authors
Schünemann, H. J., Hill, S. R., Kakad, M., Bellamy, R., Uyeki, T. M., Hayden, F. G., Yazdanpanah, Y., Beigel, J., Chotpitayasunondh, T., Del Mar, C., Farrar, J., Hien, T. T., Özbay, B., Sugaya, N., Fukuda, K., Shindo, N., Stockman, L., Vist, G. E., Croisier, A., Nagjdaliyev, A., Roth, C., Thomson, G., Zucker, H., & Oxman, A. D.
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2007-01
Volume
7
Issue
1
Pages
21-31
ISSN
1473-3099 (ISSN-L)
OpenAlex
W2105531994
Cited by
178
References
5
FWCI
17.49
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. https://app.cochat.ai/papers/10.1016/s1473-3099(06)70684-3
The paper
Schünemann, H. J., Hill, S. R., Kakad, M., Bellamy, R., Uyeki, T. M., Hayden, F. G., Yazdanpanah, Y., Beigel, J., Chotpitayasunondh, T., Del Mar, C., Farrar, J., Hien, T. T., Özbay, B., Sugaya, N., Fukuda, K., Shindo, N., Stockman, L., Vist, G. E., Croisier, A., . . . Oxman, A. D. (2007). WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(06)70684-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.